Chemical compounds
US12103921B2 · kind B2 · utility
0Cited by
12References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2023 |
| Grant date | Oct 1, 2024 |
| Priority date | — |
| Expiry date | Jun 12, 2043 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to pyrazole derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes.More particularly the invention relates to HbS modulators of formula (I) HbS modulators are potentially useful in the treatment of a wide range of disorders, including sickle cell disease (SCD).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.